Search
forResearch 10 of 494
- What does the research say about androgen use and cerebrovascular events?
- Hidradenitis suppurativa and major adverse cardiac events: A systematic review and meta-analysis
- EXPERIENCE WITH ANIFROLUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH NEUROLOGICAL MANIFESTATIONS
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Reporting on Adverse Clinical Events
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Gender-Affirming Hormone Therapy for Transgender Females
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →